Fig. 4From: Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomesAnnual monetised QALYs, net costs of delivery and net monetary benefit – Musculoskeletal disease interventions 1994–2013Back to article page